Company Description
IDEC Pharmaceuticals Corporation. The Group's principal activities are the research, development, manufacture and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. The Group's two ...
More
Related Business Topics
Breaking News
Reuters - November 24, 2009 2:03 PM
CAMBRIDGE, Mass.--(Business Wire)-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Piper Jaffray 21st Annual Health Care Conference on Wednesday, ...
Reuters - November 23, 2009 5:45 AM
Experienced Drug Hunters Armed with Structure-Based G Protein-Coupled Receptor (GPCR) Drug Discovery Technology From The Scripps Research Institute SAN DIEGO--(Business Wire)-- Receptos, Inc., a privately held biopharmaceutical company, announced the ...
Reuters - November 02, 2009 5:49 AM
Continued Uptake of Humira Will be the Greatest Contributor to Market Growth Over the Next Five Years, According to a New Report from Decision Resources WALTHAM, Mass., Nov. 2 /PRNewswire/ -- Decision Resources, one of the world's leading research and ...
Reuters - September 09, 2009 2:46 PM
CAMBRIDGE, Mass.--(Business Wire)-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference on Tuesday, ...
Forbes.com - September 09, 2009 2:32 PM
, 4:51 PM ET BusinessWire - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference on Tuesday, September 15, ...
Vaccines for Children
Has your child received all the recommended vaccines?
www.First5California.com
Has your child received all the recommended vaccines?
www.First5California.com
